Nathalie Dompé is Co-CEO of Dompé farmaceutici. Nathalie is responsible for the oversight, market development, and strategic approval of all new drugs launched by Dompé in the United States. She explores new opportunities for the company through interactions with other business leaders in the pharmaceutical and high tech industries.

Nathalie is concurrently CEO Dompé Holdings, a diversified holding company in Europe with business interests in pharmaceuticals, agriculture, and hi-tech. She sits on the board of several companies including Movendo, Philogen and Dompé farmaceutici. Nathalie graduated with Honors in Business Administration from Bocconi University in Milan. In her free time Nathalie enjoys spending time with her family in the Bay Area, and abroad.

A highly accomplished senior executive in the pharmaceutical industry with over 25 years of experience, Sullivan excels in strategic planning, operational efficiency, product launches in the rare disease space, and P&L management.

Her impressive track record, from Pfizer to Amgen, demonstrates her leadership acumen, making her a valuable asset of our organization. During her tenure at Amgen, she played a pivotal role in integrating strategic acquisitions and has been Vice President & Managing Director for Amgen, Australia & New Zealand.

Sullivan earned a Bachelor of Science in Biotechnology from the University of North Florida and completed post-baccalaureate work at Duquesne University with a concentration in chemistry.

Brian joined Dompé in 2019 and is responsible for leading the US Marketing and Market Access teams (including field patient access managers and payer national account managers), Biotech Global Product Commercial Strategy (approved and pipeline products), Analytics (including Market Research and Forecasting), and Customer Operations (responsible for US supply chain strategy/execution, patient HUB, and specialty pharmacies).

Before joining Dompé, Brian was the head of Commercial for Achaogen, a biopharmaceutical company that develops and commercializes antibacterial agents. Prior to that, he spent ten years at Genentech across many therapeutic areas—including ophthalmology, oncology, cardiovascular/stroke, cystic fibrosis—in various global product strategy and marketing leadership roles. Brian also worked in biotech consulting for ZS Associates and as a chemical engineer at BASF Corporation. He has lived in New Jersey, North Carolina, Texas, and Louisiana across his various roles. Brian holds a BS in chemical engineering from Pennsylvania State University and an MBA from Carnegie Mellon University. He is on the board of trustees at the Carey School and on the board of Hillsborough Little League.

Brian enjoys spending his free time with his family, watching Pittsburgh sports teams, and playing ice hockey.

Paul Curtin has extensive global corporate leadership experience across a broad range of legal areas: compliance, regulatory, privacy, and US Department of Justice investigations/settlements, including significant ex-US exposure with anti-corruption and anti-money-laundering work within the biotech and pharmaceutical industries. He has developed and managed five corporate compliance and privacy programs and spearheaded compliance and privacy matters in 75 countries within North America, EMEA, LATAM, and Asia-Pacific.

Most recently, as Global Chief Compliance Officer & Chief Privacy Officer at Intercept Pharmaceuticals, Paul directed global legislative and regulatory developments that impacted drug research, development, and commercialization, including GDPR, FCPA, AML, Customs & Trade, and Antitrust. Prior to joining Intercept, he was Compliance Officer, International Markets & Research, Development & Manufacturing at Allergan plc.

Previously, Paul held senior compliance positions at Clinical Data Inc., Acorda Therapeutics Inc., Applied Biosystems Inc., and Purdue Pharma L.P. Early in his career, he was a corporate, healthcare, and regulatory attorney with Wiggin and Dana.  

Paul holds a JD from the Albany Law School of Union University in Albany, NY, and a BA in English Literature and Irish Politics & Literature from Boston College in Chestnut Hill, MA. He is certified as a European Healthcare Compliance Professional, a Compliance and Ethics Professional (CCEP), and a Healthcare Compliance Professional. He has been admitted to the bar in Connecticut and New York, the United States Federal Court, District of Connecticut, Southern and Eastern Districts of New York, and the United States Court of Appeals for the Second Circuit.

Sheila joined Dompé in 2020. In her role she is accountable for the commitment to and further strengthening of the US Compliance Program through continuous improvement of policies, procedures, and applicab!e standards set forth by the Office of lnspector General. Sheila comes to Dompé with a wealth of experience and knowledge within the US health-care compliance and legal arena.

Prior to joming Dompé, Sheila held several positions in health-care compliance, including associate general counsel at Abigall Hearthcare lnc. and the compliance business partner for the lnflammation, Oncology, and Nephrology businesses and Value. Access & Government Pricing function at Amgen. lnc. She was also instrumental in the task force that established a robust health-care compliance function at Onyx Pharmaceuticals, lnc. This endeavor translated into building out the seven pillars of a strong compliance program as set and required by the US Office of lnspector General.

Sheila has always been passionate about contributing to humanitarian efforts on both a local and a global scale. She volunteers at her local church and several intenational agencies to assist with the needs of communnities that are often set aside by the norms of society. She loves music and is a professional dancer and avid kickboxer.

Georgea joined Dompé in 2018 to build the US Medical Affairs team. She now leads that group, which includes the MSL team, medical information, communications, and operations as well as post-marketing clinical development and operations across therapeutic areas. She has extensive experience and clinical expertise in ophthalmology, diabetes, pain, neurology, oncology, and cardiology and has held multiple roles spanning both medical and commercial organizations.

Prior to joining Dompé, Georgea held marketing and medical leadership positions—her most recent at Shire Pharmaceuticals—and led her own corporate consulting practice. She earned a Doctor of Pharmacy from Massachusetts College of Pharmacy and Health Sciences and is a licensed pharmacist in Massachusetts. She is also a certified immunizing pharmacist and certified diabetes patient educator.

Georgea sits on the board of trustees for the Hellenic Nursing and Rehabilitation Center and Hellenic Women’s Benevolent Association. Her true passion is performing charitable work for underserved communities and children with rare diseases.